IRIS UniCatt

Ciccarelli, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.542
NA - Nord America 2.475
AS - Asia 1.016
SA - Sud America 262
AF - Africa 55
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.396
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.396
DE - Germania 1.014
IT - Italia 689
SE - Svezia 404
FR - Francia 356
SG - Singapore 353
CN - Cina 302
PL - Polonia 276
BR - Brasile 236
GB - Regno Unito 210
UA - Ucraina 137
IE - Irlanda 118
IN - India 79
FI - Finlandia 69
ID - Indonesia 66
CA - Canada 49
ES - Italia 49
KR - Corea 47
RU - Federazione Russa 39
AU - Australia 36
BE - Belgio 31
TR - Turchia 31
PT - Portogallo 29
HK - Hong Kong 28
NL - Olanda 23
MX - Messico 21
AT - Austria 18
CI - Costa d'Avorio 16
IR - Iran 14
PH - Filippine 13
RO - Romania 12
VN - Vietnam 12
CZ - Repubblica Ceca 11
GR - Grecia 11
JP - Giappone 11
NO - Norvegia 9
ZA - Sudafrica 9
CH - Svizzera 8
CM - Camerun 8
AR - Argentina 7
NZ - Nuova Zelanda 7
NG - Nigeria 6
TW - Taiwan 6
BD - Bangladesh 5
CO - Colombia 5
PK - Pakistan 5
UZ - Uzbekistan 5
VE - Venezuela 5
CL - Cile 4
HR - Croazia 4
IQ - Iraq 4
LT - Lituania 4
QA - Qatar 4
TH - Thailandia 4
UG - Uganda 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
JM - Giamaica 3
LB - Libano 3
MA - Marocco 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
EG - Egitto 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MM - Myanmar 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SM - San Marino 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SR - Suriname 1
UY - Uruguay 1
Totale 7.396
Salva come PNG Salva come JPEG
Città #
Chandler 472
Kraków 263
Singapore 203
Ashburn 166
Milan 150
Jacksonville 121
Dublin 115
New York 113
San Mateo 102
Ann Arbor 83
Cattolica 77
Nanjing 64
Jakarta 62
Nürnberg 58
Dearborn 54
Redwood City 52
Wilmington 47
Boston 45
Houston 39
Woodbridge 39
Los Angeles 35
Redmond 34
Helsinki 33
London 31
Lawrence 28
Princeton 28
Rome 28
Brussels 25
Ottawa 24
Paris 24
Izmir 23
Lancaster 23
Frankfurt am Main 22
Moscow 22
Seattle 22
Beijing 21
Marseille 19
Nanchang 19
The Dalles 19
Augusta 18
Chicago 17
Mountain View 16
Fairfield 15
Hefei 15
Shenyang 15
Abidjan 14
Bremen 14
Catania 14
Hong Kong 14
Norwalk 14
São Paulo 14
Leawood 13
Madrid 13
Vienna 13
Changsha 12
Toronto 12
Munich 11
Rio de Janeiro 11
Amsterdam 10
Boardman 10
Brescia 10
Cantù 10
Florence 10
Glasgow 10
Guangzhou 10
Kunming 10
Lauterbourg 10
Seoul 10
Hyderabad 9
Andover 8
Brasília 8
Cambridge 8
Capua 8
Hebei 8
Jiaxing 8
Melbourne 8
Oslo 8
Turin 8
University Park 8
Düsseldorf 7
Falls Church 7
Kish 7
Lisbon 7
Pune 7
Roubaix 7
San Francisco 7
Warsaw 7
Bologna 6
Council Bluffs 6
Cusano Milanino 6
Davao City 6
Detroit 6
Fremont 6
Modena 6
Rochdale 6
San Jose 6
Shanghai 6
Trieste 6
Washington 6
Albuquerque 5
Totale 3.392
Salva come PNG Salva come JPEG
Nome #
The effects of switching from dolutegravir/abacavir/ lamivudine to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV on neuropsychiatric symptoms: preliminary findings from a randomised study 394
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 332
OXFORD COGNITIVE SCREEN (OCS) FEASIBILITY IN THE STROKE UNIT SETTING 284
Semantic memory in Object Use 249
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 235
Narrative discourse in logopenic variant of PPA: a multi-level approach 235
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 196
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 181
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 180
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 174
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 169
Primary progressive aphasia: linguistic patterns and clinical variants 166
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 163
AN ATTEMPT TO LOOK FOR DIFFERENCE BETWEEN DEGENERATIVE AND VASCULAR APHASIA: A DATA-DRIVEN CLUSTER ANALYSIS. 154
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 150
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 149
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 147
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA 145
POST-STROKE QUALITY OF LIFE AND COGNITIVE FUNCTIONING: A LONGITUDINAL STUDY 126
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 125
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 125
Unilateral Spatial Neglect in Degenerative Brain Pathology 122
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 121
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 119
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 118
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 117
Cognitive reserve and neuropsychological functioning in older HIV-infected people 115
Effect of aging and human immunodeficiency virus infection on cognitive abilities 114
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. 108
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 108
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 108
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 105
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 101
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 100
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 99
Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment 98
The facial emotion recognition deficit in Parkinson's disease: Implications of a visual scanning strategy 98
Posterior AD-type pathology: cognitive subtypes emerging from a cluster analysis 97
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 97
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 94
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 92
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 91
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 90
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 85
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 82
Writing errors in primary progressive aphasia 79
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 76
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 76
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 74
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 74
Liver fibrosis is associated with cognitive impairment in people living with HIV 67
Degenerative and Vascular Fluent Aphasia: Looking for Differences 66
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 66
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? 56
HIV 55
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 53
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population 51
Cognitive reserve: a multidimensional protective factor in Parkinson's disease related cognitive impairment 50
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 44
Naming of grammatical classes in frontotemporal dementias: Linguistic and non linguistic factors contribute to noun-verb dissociation 42
Writing errors in primary progressive aphasia 36
Totale 7.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 0 0 0 0 0 35
2020/2021465 48 36 7 27 46 28 56 14 59 53 72 19
2021/2022679 51 40 21 90 32 30 30 111 23 51 67 133
2022/20231.439 167 205 77 213 90 153 77 136 179 37 74 31
2023/2024939 43 172 38 60 59 194 64 52 41 46 96 74
2024/20251.464 28 53 195 78 161 57 106 80 212 120 256 118
Totale 7.523